HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haixin Dong Selected Research

asialo-von Willebrand Factor

4/2021Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haixin Dong Research Topics

Disease

2Neoplasms (Cancer)
01/2018 - 10/2017
2Parkinson Disease (Parkinson's Disease)
08/2011 - 08/2008
1Thrombosis (Thrombus)
04/2021
1Vascular Diseases (Vascular Disease)
04/2021
1Invasive Pulmonary Aspergillosis
03/2019
1Hypersensitivity (Allergy)
10/2017
1Autoimmune Diseases (Autoimmune Disease)
10/2017
1Glioma (Gliomas)
08/2016
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2014

Drug/Important Bio-Agent (IBA)

2Therapeutic UsesIBA
08/2016 - 02/2014
2alpha-Galactosidase (Beano)IBA
08/2011 - 08/2008
1asialo-von Willebrand FactorIBA
04/2021
1von Willebrand FactorIBA
04/2021
1Glycoproteins (Glycoprotein)IBA
04/2021
1galactomannanIBA
03/2019
115-deoxyprostaglandin J2IBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
10/2017
1Biological ProductsIBA
10/2017
1graphene oxideIBA
08/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2016
1Prostaglandins DIBA
08/2016
1Transferrin (beta 2 Transferrin)IBA
08/2016
1Inosine Triphosphate (ITP)IBA
02/2014
1halofuginoneIBA
02/2014
1AcidsIBA
08/2008

Therapy/Procedure

2Therapeutics
01/2018 - 08/2016
1Transplantation
10/2017
1Photothermal Therapy
08/2016